ValueLabs Announces Strategic Pivot—Exclusively Offering Outcome-Based Engagements Globally

ValueLabs Announces Strategic Pivot—Exclusively Offering Outcome-Based Engagements Globally

Company shifts away from Time & Materials contracts for all new clients, embracing outcome-driven, AI-powered delivery models. HYDERABAD, India, May 30, 2025 /PRNewswire/ -- ValueLabs, a global leader in Agentic AI Services, today announced a...

OHI Group S.A. Announces Intention to Submit Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering

OHI Group S.A. Announces Intention to Submit Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering

LUXEMBOURG, May 29, 2025 /PRNewswire/ -- OHI Group S.A., a societe anonyme organized under laws of Luxembourg (the "Issuer"), today announced that it intends to confidentially submit a draft registration statement on Form F-1 with the U.S....

PROGOLD ACQUIRES ABI MANUFACTURING INTERNATIONAL LTD

PROGOLD ACQUIRES ABI MANUFACTURING INTERNATIONAL LTD

A new phase of strategic expansion in Asia VICENZA, Italy, May 29, 2025 /PRNewswire/ -- Progold S.p.A., an Italian company based in Trissino (Vicenza) and a global leader in the development and production of precious metal alloys and advanced...

Lufax Announces Extraordinary General Meeting on June 25, 2025

Lufax Announces Extraordinary General Meeting on June 25, 2025

SHANGHAI, May 29, 2025 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced that it will hold an extraordinary general...

Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein(a) in The National Lipid Association (NLA) Scientific Sessions 2025

Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein(a) in The National Lipid Association (NLA) Scientific Sessions 2025

SHANGHAI, May 29, 2025 /PRNewswire/ -- Rona Therapeutics, a global leading RNA therapy company, today announced preclinical data for its self-developed RNA interference (RNAi) therapy RN026 at the National Lipid Association (NLA) Annual Scientific...

Yum China Announces US$510 Million Share Repurchase Agreements for Second Half of 2025 as Part of Broader Capital Return Plan

Yum China Announces US$510 Million Share Repurchase Agreements for Second Half of 2025 as Part of Broader Capital Return Plan

SHANGHAI, May 29, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced that it has entered into share repurchase agreements in the U.S. and Hong Kong for an aggregate repurchase amount of...

OneConnect Announces Annual General Meeting Results

OneConnect Announces Annual General Meeting Results

SHENZHEN, China, May 29, 2025 /PRNewswire/ -- OneConnect Financial Technology Co., Ltd. ("OneConnect" or the "Company") (NYSE: OCFT and HKEX: 6638), a leading technology-as-a-service provider for the financial services industry in China, today...

TAQA Saudi Arabia Announces CEO Transition as Part of Strategic Growth Agenda

TAQA Saudi Arabia Announces CEO Transition as Part of Strategic Growth Agenda

Company prepares for the next phase of profitable growth, market expansion, and digital transformation. DHAHRAN, Saudi Arabia, May 29, 2025 /PRNewswire/ -- Industrialization and Energy Services Company ("TAQA"), a global leader in energy and...

Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies

Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies

SAN FRANCISCO and SUZHOU, China, May 29, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

Doba Unveils Summer Dropshipping Deals to Capitalize on Seasonal E-Commerce Trends

Doba Unveils Summer Dropshipping Deals to Capitalize on Seasonal E-Commerce Trends

LEHI, Utah, May 29, 2025 /PRNewswire/ -- Doba, a leading dropshipping platform, announces its Summer Dropshipping Deals event, running from May 26 to July 14, 2025. This initiative offers exclusive discounts on a curated selection of wholesale...

  • 1
  • ...
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • ...
  • 136
  • menu
    menu